| A biomarker panel for acute graft-versus-host disease S Paczesny, OI Krijanovski, TM Braun, SW Choi, SG Clouthier, R Kuick, ... Blood, The Journal of the American Society of Hematology 113 (2), 273-278, 2009 | 473 | 2009 |
| ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease NT Connell, VH Flood, R Brignardello-Petersen, R Abdul-Kadir, ... Blood advances 5 (1), 301-325, 2021 | 239 | 2021 |
| New therapies for hemophilia AC Weyand, SW Pipe Blood, The Journal of the American Society of Hematology 133 (5), 389-398, 2019 | 180 | 2019 |
| Efanesoctocog alfa prophylaxis for patients with severe hemophilia A A Von Drygalski, P Chowdary, R Kulkarni, S Susen, BA Konkle, ... New England Journal of Medicine 388 (4), 310-318, 2023 | 83 | 2023 |
| Zebrafish as a model system for the study of hemostasis and thrombosis AC Weyand, JA Shavit Current opinion in hematology 21 (5), 418-422, 2014 | 74 | 2014 |
| Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo R Khoriaty, GG Hesketh, A Bernard, AC Weyand, D Mellacheruvu, G Zhu, ... Proceedings of the National Academy of Sciences 115 (33), E7748-E7757, 2018 | 71 | 2018 |
| Cost-effectiveness and budget impact of emicizumab prophylaxis in haemophilia A patients with inhibitors PA Cortesi, G Castaman, G Trifirò, SS Creazzola, G Improta, G Mazzaglia, ... Thrombosis and Haemostasis 120 (02), 216-228, 2020 | 69 | 2020 |
| Sexism in the management of bleeding disorders AC Weyand, PD James Research and Practice in Thrombosis and Haemostasis 5 (1), 51-54, 2021 | 67 | 2021 |
| An international survey to inform priorities for new guidelines on von Willebrand disease MA Kalot, M Al‐Khatib, NT Connell, V Flood, R Brignardello‐Petersen, ... Haemophilia 26 (1), 106-116, 2020 | 44 | 2020 |
| Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies AC Weyand, VH Flood, JA Shavit, SW Pipe Blood Advances 3 (18), 2748-2750, 2019 | 40 | 2019 |
| Von Willebrand disease: current status of diagnosis and management AC Weyand, VH Flood Hematology/Oncology Clinics 35 (6), 1085-1101, 2021 | 39 | 2021 |
| von Willebrand disease: proposing definitions for future research NT Connell, PD James, R Brignardello-Petersen, R Abdul-Kadir, B Ameer, ... Blood Advances 5 (2), 565-569, 2021 | 37 | 2021 |
| Modeling disorders of blood coagulation in the zebrafish CA Kretz, AC Weyand, JA Shavit Current pathobiology reports 3, 155-161, 2015 | 37 | 2015 |
| Prevalence of iron deficiency and iron-deficiency anemia in US females aged 12-21 years, 2003-2020 AC Weyand, A Chaitoff, GL Freed, M Sholzberg, SW Choi, PT McGann JAMA 329 (24), 2191-2193, 2023 | 35 | 2023 |
| Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis AC Weyand, SJ Grzegorski, MS Rost, KI Lavik, AC Ferguson, M Menegatti, ... Blood Advances 3 (11), 1670-1680, 2019 | 28 | 2019 |
| Eliminating race-based reference ranges in haematology: a call to action AC Weyand, PT McGann The Lancet Haematology 8 (6), e462-e466, 2021 | 26 | 2021 |
| Lessons learned from the COVID‐19 pandemic blood supply crisis PT McGann, AC Weyand Journal of Hospital Medicine 17 (7), 574, 2022 | 24 | 2022 |
| The evolution of recombinant factor replacement for hemophilia AD Sankar, AC Weyand, SW Pipe Transfusion and Apheresis Science 58 (5), 596-600, 2019 | 24 | 2019 |
| Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues AC Weyand, RF Sidonio Jr, M Sholzberg Haemophilia 28, 18-25, 2022 | 23 | 2022 |
| Sex specific definitions of anaemia contribute to health inequity and sociomedical injustice AC Weyand, PT McGann, M Sholzberg The Lancet Haematology 9 (1), e6-e8, 2022 | 23 | 2022 |
